CClinicalTrials.gg
CompletedNCT05512247Updated Jul 13, 2026

Hearty Meals for Mom- Pilot Study of Meal Delivery for Cardiometabolic Health During Pregnancy

An interventional study of Meal Delivery in Diet, Healthy and Pregnancy, sponsored by University of Alabama at Birmingham. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

This study is being done to assess the feasibility, acceptability, and preliminary impact of a meal delivery intervention designed to improve diet quality and promote appropriate gestational weight gain among predominantly Black and low-income pregnant women with overweight or obesity. This will be done by 1) assessing the feasibility and acceptability of the meal delivery intervention; 2) investigating changes in patient-reported diet quality, barriers to healthy eating, and food security; and 3) exploring the preliminary impact of the meal delivery intervention on gestational weight gain and blood pressure and estimate the effect size of the intervention relative to a de-identified non-randomized control group that will be derived from de-identified hospital records.

Read the detailed description

Subjects will receive 10 home-delivered meals per week from about 20 weeks gestation until 40 weeks gestation.

02

Conditions studied

  • Diet, Healthy
  • Pregnancy

Keywords

  • Meal Delivery
  • Maternal Overweight or Obesity
  • Blood Pressure
  • Food Security
  • Pregnancy
  • Gestational Weight Gain
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 17 is below the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Medicaid eligible and/or have a household income at or below 185 percent of the federal poverty line
  • 18 years of age or older
  • \<= 19 weeks gestation
  • Currently experiencing a singleton pregnancy
  • Receiving prenatal care at a University of Alabama at Birmingham clinic
  • Planning to deliver at the University of Alabama at Birmingham
  • Residing within the meal company's delivery radius
  • Body mass index >= 25
  • Willing to consent

Exclusion criteria

Exclusion Criteria:

  • Self-reported major health condition (such as renal disease, cancer, or Type 1 or Type 2 diabetes)
  • Current treatment for severe psychiatric disorder (such as schizophrenia)
  • Current substance abuse
  • Self-reported diagnosis of anorexia or bulimia
  • Known fetal anomaly
  • Current use of medication expected to significantly impact body weight
  • Planned termination of the current pregnancy
  • Participation in another dietary and/or weight management intervention during the current pregnancy
  • Unwilling or unable to understand and communicate in English
  • Unwilling or unable to consume study meals
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Experimental
    Meal Delivery

    Behavioral intervention program designed to improve diet quality and promote healthy weight gain in women with overweight/obesity through meal delivery and behavioral strategies during pregnancy.

    Behavioral: Meal Delivery

Interventions

  • BehavioralMeal Delivery

    10 home-delivered meals per week provided by a local meal delivery company + brief weekly behavioral support with study staff

06

What researchers measure

Primary outcomes

  1. Change in Healthy Eating Index score from baseline to follow-up

    Determined based on the Healthy Index Score, in which 100 indicates complete alignment with the Dietary Guidelines for Americans and 0 is the minimum score, as calculated from three 24-hour dietary recalls conducted on non-consecutive days (2 weekdays + 1 weekend day) at each time point.

    Time frame: three 24-hour dietary recalls on non-consecutive days at baseline (18-22 weeks gestation) and follow-up (33-37 weeks gestation)

Secondary outcomes

  1. Change in Food Security

    Determined using the 18-item United States (US) Household Food Security Survey Module based on the previous 30 days. Adult food security scores range from 0 to 10, with lower values indicating greater food security.

    Time frame: baseline (18-22 weeks gestation), (33-37 weeks gestation)

  2. Change in Barriers to Healthy Eating

    Participants will be asked to score 5 statements corresponding to different barriers to healthy eating on a 5-point Likert scale ranging from strongly agree to strongly disagree (adapted from Sibai D et al. 2022). Changes in the distribution of responses to each barrier will be assessed, as well as changes in the proportion of women somewhat/strongly agreeing with each barrier will be compared.

    Time frame: baseline (18-22 weeks gestation), follow-up (33-37 weeks gestation)

  3. Study Participation Rate

    Percentage of eligible subjects who agreed to participate out of those who were screened.

    Time frame: baseline (18-22 weeks gestation)

  4. Participant Retention

    The proportion of enrolled participants who complete follow-up

    Time frame: baseline (18-22 weeks gestation), follow-up (33-37 weeks gestation)

  5. Participant Adherence to Intervention

    Proportion of weekly study meals participants consumed based on responses to weekly electronic surveys in which participants will report the number of study meals a) they consumed, b) other household members consumed, or c) that were uneaten.

    Time frame: Collected weekly from intervention start (20-24 weeks gestation) to intervention end (40 weeks gestation)

  6. Change in Participant Satisfaction with Diet

    To assess satisfaction with the study intervention, the 28-item Diet Satisfaction Questionnaire will be used in which participants respond to 28 statements using a 5-point Likert scale. Responses are average to produce a total diet satisfaction score ranging from 1-5. Changes in overall diet satisfaction, as well as changes in subscale scores for Cost Factor and Planning \& Preparation Factor will be examined from baseline to follow-up.

    Time frame: baseline (18-22 weeks gestation), follow-up (33-37 weeks gestation)

Other outcomes

  1. Change in Blood Pressure

    Systolic and diastolic blood pressure measured at each prenatal visit will be retrieved from medical records for all participants at the end of the intervention.

    Time frame: First prenatal visit through delivery (Collected once at study end from medical record)

  2. Gestational weight gain

    Weight measured at each prenatal visit will be retrieved from medical records for all participants at the end of the intervention and used to calculate total gestational weight gain and rate of gestational weight gain.

    Time frame: First prenatal visit through delivery (Collected once at study end from medical record)

07

Study locations

1 site
  • University of Alabama at Birmingham
    Birmingham, Alabama 35294, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) that underlie the results reported in a publication will be made available upon request beginning 9 months and ending 36 months following article publication. The research team will keep a record of all individuals and/or research teams who request and receive a copy of the project data. Interested investigators will be asked to submit a document indicating the specific aims of the analyses, the analytic plan, available resources for completing the proposed project, proposed timeline, and goals (i.e., manuscripts, presentations, and/or grant applications). The PI and research team will review these requests to determine whether the proposed analyses constitute an innovative and significant exploration of the data, whether the proposed team has sufficient resources to complete the request, and whether data will be adequately protected and managed.

Supporting information: Study protocol, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05512247
Lead sponsor
University of Alabama at Birmingham
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD)
Responsible party
Camille S Worthington, PhD (Primary Investigator, University of Alabama at Birmingham) — Principal investigator
First posted
Aug 23, 2022
Start date
Oct 5, 2023
Primary completion
May 31, 2026
Completion
May 31, 2026
Last update
Jul 13, 2026

Study contacts

Camille S Worthington, PhD
principal investigator · University of Alabama at Birmingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion